{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:51:13Z","timestamp":1790171473341,"version":"4.1.0"},"reference-count":70,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"QuIHN"},{"name":"Australian Government Research Training Program Scholarship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Highly effective direct-acting antiviral (DAA) therapies for hepatitis C (HCV) have been available in Australian prisons since 2016. To address treatment interruption following release from prisons, the Queensland Injector\u2019s Health Network (QuIHN) launched a Prison Transition Service (PTS) in south-east Queensland, Australia. Presently, the factors associated with continuity of post-release HCV care are poorly understood. The objective of this qualitative study was to explore the barriers and facilitators to HCV treatment among people recently released from prisons among PTS clients and stakeholders. Qualitative interviews were conducted with 27 participants, namely, 13 clients and 14 stakeholders (health and community support workers) of the PTS. We conducted thematic analysis using the framework of person-, provider-, and system-level barriers and facilitators. Person-level barriers included competing priorities post-release, while facilitators included self-improvement after treatment completion, preventing transmission to family, and social support. Provider-level treatment barriers included enacted stigma, limited prison health service capacity, and post-release health system challenges. Systemic barriers included stigma relating to HCV, injecting drug use, incarceration, and limited availability of harm reduction services. Policy changes and investment are required to expand HCV treatment in south-east Queensland prisons to facilitate patient navigation into community care. In terms of reducing stigma among health staff and the general community towards people with HCV, a history of incarceration and\/or who inject drugs is crucial for improving treatment rates. Strategies such as peer-led or nurse-practitioner-led models of care may help improve treatment completion. Continuity of HCV treatment post-release from prisons is essential for Australia to meet the WHO\u2019s 2030 HCV elimination target.<\/jats:p>","DOI":"10.3390\/ijerph22020238","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:02:42Z","timestamp":1738918962000},"page":"238","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["\u2018You\u2019ve Just Got to Keep Pestering\u2019: Barriers and Enablers of Attaining Continuity of Hepatitis C Care for People Transitioning Between Prison and Community Health Services in South-East Queensland, Australia"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0629-1497","authenticated-orcid":false,"given":"Idin","family":"Panahi","sequence":"first","affiliation":[{"name":"School of Public Health, The University of Queensland, Herston, QLD 4006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8493-0974","authenticated-orcid":false,"given":"Linda A.","family":"Selvey","sequence":"additional","affiliation":[{"name":"School of Public Health, The University of Queensland, Herston, QLD 4006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheneal","family":"Puljevi\u0107","sequence":"additional","affiliation":[{"name":"School of Public Health, The University of Queensland, Herston, QLD 4006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Kvassay","sequence":"additional","affiliation":[{"name":"Queensland Injectors Health Network, Bowen Hills, QLD 4006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorrit","family":"Grimstrup","sequence":"additional","affiliation":[{"name":"Queensland Injectors Health Network, Bowen Hills, QLD 4006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2041-8864","authenticated-orcid":false,"given":"Andrew","family":"Smirnov","sequence":"additional","affiliation":[{"name":"School of Public Health, The University of Queensland, Herston, QLD 4006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/ijc.31280","article-title":"Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide: Liver cancer attributable to hepatitis viruses worldwide","volume":"142","author":"Franceschi","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_2","unstructured":"World Health Organisation (2016). Global Health Sector Strategy on Viral Hepatitis 2016\u20132021: Towards Ending Viral Hepatitis, World Health Organisation."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.3748\/wjg.v24.i44.4959","article-title":"Hepatitis elimination by 2030: Progress and challenges","volume":"24","author":"Waheed","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_4","unstructured":"Department of Health and Ageing (2018). Fifth National Hepatitis C Strategy 2018\u20132022."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.amepre.2023.06.016","article-title":"Hepatitis C Cascade of Care in the Direct-Acting Antivirals Era: A Meta-Analysis","volume":"65","author":"Wilson","year":"2023","journal-title":"Am. J. Prev. Med."},{"key":"ref_6","first-page":"101240","article-title":"Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: The AusHep study","volume":"53","author":"Bah","year":"2024","journal-title":"Lancet Reg. Health West Pac."},{"key":"ref_7","first-page":"1084","article-title":"Coming home from jail: The social and health consequences of community reentry for women, male adolescents, and their families and communities","volume":"45","author":"Freudenberg","year":"2006","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cid\/ciy210","article-title":"Demonstration of near-elimination of Hepatitis C virus among a prison population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project","volume":"67","author":"Bartlett","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2017.03.039","article-title":"Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1\u20136 without cirrhosis","volume":"67","author":"Kwo","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2019.01.012","article-title":"Outcomes of treatment for hepatitis C in prisoners using a nurse-led, state-wide model of care","volume":"70","author":"Papaluca","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jvh.12512","article-title":"The Hepatitis C virus treatment cascade at an urban postincarceration transitions clinic","volume":"23","author":"Hawks","year":"2016","journal-title":"J. Viral Hepat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.socscimed.2016.08.040","article-title":"Contextualising the social capital of Australian Aboriginal and non-Aboriginal men in prison","volume":"167","author":"Lafferty","year":"2016","journal-title":"Soc. Sci. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/jvh.12987","article-title":"Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison","volume":"25","author":"Lafferty","year":"2018","journal-title":"J. Viral Hepat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.socscimed.2013.01.031","article-title":"Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting","volume":"83","author":"Harris","year":"2013","journal-title":"Soc. Sci. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12954-018-0246-6","article-title":"A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia\u2019s prisons","volume":"15","author":"Lafferty","year":"2018","journal-title":"Harm Reduct. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/009145091304000404","article-title":"Authenticity and Diversity: Enhancing Australian Hepatitis C Prevention Messages","volume":"40","author":"Winter","year":"2013","journal-title":"Contemp. Drug Probl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0004865815620703","article-title":"How the prison-to-community transition risk environment influences the experience of men with co-occurring mental health and substance use disorder","volume":"50","author":"Denton","year":"2017","journal-title":"Aust. N. Z. J. Criminol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"108970","DOI":"10.1016\/j.drugalcdep.2021.108970","article-title":"The Prison and Transition Health (PATH) cohort study: Prevalence of health, social, and crime characteristics after release from prison for men reporting a history of injecting drug use in Victoria, Australia","volume":"227","author":"Stewart","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"ref_19","unstructured":"Goffman, E. (1991). Stigma, Simon & Schuster."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/13548500600595178","article-title":"Measuring HIV stigma: Existing knowledge and gaps","volume":"11","author":"Nyblade","year":"2006","journal-title":"Psychol. Health Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s10461-009-9593-3","article-title":"From Conceptualizing to Measuring HIV Stigma: A Review of HIV Stigma Mechanism Measures","volume":"13","author":"Earnshaw","year":"2009","journal-title":"AIDS Behav."},{"key":"ref_22","unstructured":"Broady, T., Brener, L., Hopwood, M., Cama, E., and Treloar, C. (2020). Stigma Indicators Monitoring Project: Summary Report, UNSW Centre for Social Research in Health. Phase Two."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/cbm.2326","article-title":"Self-stigma of incarceration and its impact on health and community integration","volume":"34","author":"Brehmer","year":"2024","journal-title":"Crim Behav Ment Health"},{"key":"ref_24","first-page":"130","article-title":"Behind closed doors, no one sees, no one knows\u2019: Hepatitis C, stigma and treatment-as-prevention in prison","volume":"30","author":"Lafferty","year":"2018","journal-title":"Crit. Public Health"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/jvh.13801","article-title":"Factors influencing compliance with Hepatitis C treatment in patients transitioning from prison to community\u2014A summary scoping review","volume":"30","author":"McKeever","year":"2023","journal-title":"J. Viral. Hepat."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jvh.13220","article-title":"Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: Findings from a systematic review","volume":"27","author":"Dussault","year":"2020","journal-title":"J. Viral. Hepat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","article-title":"The \u2018risk environment\u2019: A framework for understanding and reducing drug-related harm","volume":"13","author":"Rhodes","year":"2002","journal-title":"Int. J. Drug Policy"},{"key":"ref_28","unstructured":"World Health Organization (2010). A Conceptual Framework for Action on the Social Determinants of Health, World Health Organization."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10826084.2020.1846198","article-title":"Reasons for Not Seeking Hepatitis C Treatment among People Who Inject Drugs","volume":"56","author":"Morris","year":"2020","journal-title":"Subst. Use Misuse"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual. Res. Psychol."},{"key":"ref_31","unstructured":"Q.I.P. Ltd. (2018). NVivo, QSR International Pty Ltd.. Available online: https:\/\/www.qsrinternational.com\/nvivo-qualitative-data-analysis-software\/home."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugalcdep.2016.08.640","article-title":"Resumption of injecting drug use following release from prison in Australia","volume":"168","author":"Winter","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"ofac350","DOI":"10.1093\/ofid\/ofac350","article-title":"Care Navigation Increases Initiation of Hepatitis C Treatment After Release From Prison in a Prospective Randomized Controlled Trial: The C-LINK Study","volume":"9","author":"Papaluca","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5694\/mja2.51854","article-title":"Consensus recommendations on the management of hepatitis C in Australia\u2019s prisons","volume":"218","author":"Winter","year":"2023","journal-title":"Med. J. Aust."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Winter, R.J., Holmes, J.A., Papaluca, T.J., and Thompson, A.J. (2022). The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience. Viruses, 14.","DOI":"10.3390\/v14030497"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"102608","DOI":"10.1016\/j.drugpo.2019.102608","article-title":"Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England","volume":"75","author":"Mohamed","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"v17","DOI":"10.1093\/jac\/dkz452","article-title":"From peer-based to peer-led: Redefining the role of peers across the hepatitis C care pathway: HepCare Europe","volume":"74","author":"Surey","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12954-019-0313-7","article-title":"Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.(Report)","volume":"16","author":"Crowley","year":"2019","journal-title":"Harm Reduct. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1353\/hpu.2018.0111","article-title":"The New Mexico Peer Education Project: Filling a Critical Gap in HCV Prison Education","volume":"29","author":"Thornton","year":"2018","journal-title":"J. Health Care Poor Underserved"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1097\/QAD.0b013e3283320dce","article-title":"HIV-related stigma and psychological distress: The harmful effects of specific stigma manifestations in various social settings","volume":"23","author":"Stutterheim","year":"2009","journal-title":"AIDS"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/14461242.2015.1126187","article-title":"Multiple stigmas, shame and historical trauma compound the experience of Aboriginal Australians living with hepatitis C","volume":"25","author":"Treloar","year":"2016","journal-title":"Health Sociol. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1071\/PY21055","article-title":"Barriers and enablers to hepatitis C treatment among clients of Aboriginal Community Controlled Health Services in South East Queensland, Australia: A qualitative enquiry","volume":"28","author":"Puljevic","year":"2022","journal-title":"Aust. J. Prim Health"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/13557858.2015.1004870","article-title":"Care and treatment of hepatitis C among Aboriginal people in New South Wales, Australia: Implications for the implementation of new treatments","volume":"21","author":"Treloar","year":"2016","journal-title":"Ethn. Health"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"111013","DOI":"10.1016\/j.drugalcdep.2023.111013","article-title":"Shame and stigma in association with the HCV cascade to cure among people who inject drugs","volume":"253","author":"Batchelder","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0277-9536(02)00304-0","article-title":"HIV and AIDS-related stigma and discrimination: A conceptual framework and implications for action","volume":"57","author":"Parker","year":"2003","journal-title":"Soc. Sci. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0277-9536(02)00142-9","article-title":"Trust and the development of health care as a social institution","volume":"56","author":"Gilson","year":"2003","journal-title":"Soc. Sci. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drugpo.2019.02.013","article-title":"Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting","volume":"72","author":"Overton","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"ciae471","DOI":"10.1093\/cid\/ciae471","article-title":"Long-Term Outcomes of a Decentralized, Nurse-Led, Statewide Model of Care for Hepatitis C Among People in Prison in Victoria, Australia","volume":"1","author":"MacIsaac","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1525-1497.2003.20826.x","article-title":"\u201cThey treated me like a leper\u201d","volume":"18","author":"Zickmund","year":"2003","journal-title":"J. Gen. Intern. Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Turan, J.M., Elafros, M.A., Logie, C.H., Banik, S., Turan, B., Crockett, K.B., Pescosolido, B., and Murray, S.M. (2019). Challenges and opportunities in examining and addressing intersectional stigma and health. BMC Med., 17.","DOI":"10.1186\/s12916-018-1246-9"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"103455","DOI":"10.1016\/j.drugpo.2021.103455","article-title":"It is time for us all to embrace person-centred language for people in prison and people who were formerly in prison","volume":"99","author":"Harney","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"104624","DOI":"10.1016\/j.drugpo.2024.104624","article-title":"Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada","volume":"133","author":"Kronfli","year":"2024","journal-title":"Int. J. Drug Policy"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/10345329.2023.2293317","article-title":"Hyperincarceration and human rights abuses of First Nations children in juvenile detention in Queensland and the Northern Territory","volume":"37","author":"Boffa","year":"2024","journal-title":"Curr. Issues Crim. Justice"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.colegn.2019.08.006","article-title":"Aboriginal people with chronic HCV: The role of community health nurses for improving health-related quality of life","volume":"27","author":"Rashidi","year":"2020","journal-title":"Collegian"},{"key":"ref_55","unstructured":"Queensland Mental Health Commission (2020). Don\u2019t Judge, and Listen: Experiences of Stigma and Discrimination Related to Problematic Alcohol and Other Drug Use."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"102532","DOI":"10.1016\/j.drugpo.2019.07.027","article-title":"\u201cA spray bottle and a lollipop stick\u201d: An examination of policy prohibiting sterile injecting equipment in prison and effects on young men with injecting drug use histories","volume":"80","author":"Walker","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Treloar, C., McCredie, L., and Lloyd, A.R. (2016). The prison economy of needles and syringes: What opportunities exist for blood borne virus risk reduction when prices are so high?. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0162399"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Martin, N.K., Hickman, M., Spaulding, A.C., and Vickerman, P. (2020). Prisons Can Also Improve Drug User Health in the Community, Wiley Online Library.","DOI":"10.1111\/add.14971"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/add.13783","article-title":"Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland","volume":"112","author":"Stone","year":"2017","journal-title":"Addiction"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial","volume":"386","author":"Rich","year":"2015","journal-title":"Lancet"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"102693","DOI":"10.1016\/j.drugpo.2020.102693","article-title":"Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting","volume":"77","author":"Lafferty","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1753-6405.2008.00172.x","article-title":"Increased access to opioid substitution treatment in prisons is needed to ensure equivalence of care","volume":"32","author":"Larney","year":"2008","journal-title":"Aust. N. Z. J. Public Health"},{"key":"ref_63","unstructured":"Queensland Government (2020). Drug and Alcohol Strategy Action Plan 2020\u20132021."},{"key":"ref_64","unstructured":"Resolution\/Adopted by the General Assembly (2016). United Nations Standard Minimum Rules for the Treatment of Prisoners (the Nelson Mandela Rules) (Standard No. A\/RES\/70\/175). Available online: https:\/\/www.refworld.org\/legal\/resolution\/unga\/2016\/en\/119111."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1753-6405.2007.00140.x","article-title":"What have sampling and data collection got to do with good qualitative research?","volume":"31","author":"Gibbs","year":"2007","journal-title":"Aust. N. Z. J. Public Health"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41395-018-0157-x","article-title":"Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm","volume":"113","author":"Cuadrado","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/14737159.2017.1400385","article-title":"Hepatitis C point-of-care diagnostics: In search of a single visit diagnosis","volume":"17","author":"Grebely","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"104628","DOI":"10.1016\/j.drugpo.2024.104628","article-title":"Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework","volume":"134","author":"Walker","year":"2024","journal-title":"Int. J. Drug Policy"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"104461","DOI":"10.1016\/j.drugpo.2024.104461","article-title":"Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd)","volume":"129","author":"Sheehan","year":"2024","journal-title":"Int. J. Drug Policy"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e13908","DOI":"10.1111\/hex.13908","article-title":"\u2018It opened my eyes, my ears, and my heart\u2019: Codesigning a substance use disorder treatment programme","volume":"27","author":"Bosak","year":"2024","journal-title":"Health Expect"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/22\/2\/238\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:28:52Z","timestamp":1760027332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/22\/2\/238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":70,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["ijerph22020238"],"URL":"https:\/\/doi.org\/10.3390\/ijerph22020238","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}